Beyond 68Ga-labeled somatostatin analogues: is it time to say goodbye to [68Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?

被引:0
|
作者
Ninatti, Gaia [1 ,2 ]
Mapelli, Paola [2 ,3 ]
机构
[1] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy
[2] IRCCS San Raffaele Sci Inst, Nucl Med Dept, Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
关键词
D O I
10.1007/s00259-023-06275-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:2246 / 2247
页数:2
相关论文
共 50 条
  • [41] Synthesis and Characterization of a 68Ga/NIR Labeled Peptide for Somatostatin Receptor Targeting
    Hernandez-Vargas, Servando
    Ghosh, Sukhen
    Voss, Julie
    Lee, Dongyoul
    Schultz, Michael
    Azhdarinia, Ali
    PANCREAS, 2018, 47 (03) : 341 - 341
  • [42] Synthesis and characterization of a 68Ga/NIR labeled peptide for somatostatin receptor targeting
    Vargas, Servando Hernandez
    Ghosh, Sukhen
    Voss, Julie
    Lee, Dongyoul
    Schultz, Michael
    Azhdarinia, Ali
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [43] Prevalence of Bone Metastases in Neuroendocrine Neoplasms by 68Ga DOTATATE PET Scan
    Shaheen, Shagufta
    Gardner, Rebecca
    Sundaram, Vandana
    Hornbacker, Kathleen
    Moradi, Farshad
    Wu, Joy
    Kunz, Pamela
    PANCREAS, 2020, 49 (03) : 486 - 486
  • [44] Clinical impact of [68Ga] Ga-DOTA-TOC PET/CT in the management of neuroendocrine tumors.
    Palacios, J. Villa
    Luquin, T. Aroui
    Rivas-Navas, D.
    Guijarro-Caba, P.
    De Fuentes, M. Muros
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S511 - S511
  • [45] [68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications
    Giovannini, Elisabetta
    Giovacchini, Giampiero
    Borso, Elisa
    Lazzeri, Patrizia
    Riondato, Mattia
    Leoncini, Rossella
    Duce, Valerio
    Ciarmiello, Andrea
    CURRENT RADIOPHARMACEUTICALS, 2019, 12 (01) : 11 - 22
  • [46] Automated synthesis of [68Ga]oxine, improved preparation of 68Ga-labeled erythrocytes for blood-pool imaging, and preclinical evaluation in rodents
    Thompson, Stephen
    Rodnick, Melissa E.
    Stauff, Jenelle
    Arteaga, Janna
    Desmond, Timothy J.
    Scott, Peter J. H.
    Viglianti, Benjamin L.
    MEDCHEMCOMM, 2018, 9 (03) : 454 - 459
  • [47] Highly Variable Biodistribution of 68Ga Labeled Somatostatin Analogue DOTA-NOC/TATE in Neuroendocrine Tumors: Clinical Implications for Somatostatin Receptor Directed PET/CT
    Cheng, Monica
    Tann, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [48] Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
    Putzer, Daniel
    Kroiss, Alexander
    Waitz, Dietmar
    Gabriel, Michael
    Traub-Weidinger, Tatjana
    Uprimny, Christian
    von Guggenberg, Elisabeth
    Decristoforo, Clemens
    Warwitz, Boris
    Widmann, Gerlig
    Virgolini, Irene Johanna
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (03) : 364 - 372
  • [49] Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
    Daniel Putzer
    Alexander Kroiss
    Dietmar Waitz
    Michael Gabriel
    Tatjana Traub-Weidinger
    Christian Uprimny
    Elisabeth von Guggenberg
    Clemens Decristoforo
    Boris Warwitz
    Gerlig Widmann
    Irene Johanna Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 364 - 372
  • [50] Interim PET/CT with [68Ga]Ga-DOTA-peptides in NET prognostication: is Δ-radiomics the next frontier?
    Filippi, Luca
    Schillaci, Orazio
    EUROPEAN RADIOLOGY, 2024,